1. 2568 Pembrolizumab for patients with leptomeningeal disease from advanced solid tumors. (21st November 2018) Authors: Naidoo, Jarushka; Hu, Chen; Schrek, Karisa; Connolly, Roisin; Santa-Maria, Cesar; Lipson, Evan; Mehra, Ranee; Bettegowda, ; Redmond, Kristin; Venkatesan, Arun; Grossman, Stuart Journal: Journal of clinical and translational science Issue: Volume 2(2018)Supplement 1 Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 788 Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety and cerebrospinal fluid biomarkers. (10th December 2020) Authors: Naidoo, Jarushka; Schreck, Karisa; Fu, Wei; Hu, Chen; Connolly, Roisin; Santa-Maria, Cesar; Lipson, Evan; Holdhoff, Matthias; Forde, Patrick; Riemer, Joanne; Barnes, Amanda; Aygun, Nafi; Kleinberg, Lawrence; Redmond, Kristin; Douville, Christopher; Bettegowda, Chetan; Venkatesan, Arun; Grossman, ... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma. Issue 10 (24th May 2015) Authors: Gerstner, Elizabeth R.; Ye, Xiaobu; Duda, Dan G.; Levine, Michael A.; Mikkelsen, Tom; Kaley, Thomas J.; Olson, Jeffrey J.; Nabors, Burt L.; Ahluwalia, Manmeet S.; Wen, Patrick Y.; Jain, Rakesh K.; Batchelor, Tracy T.; Grossman, Stuart Journal: Neuro-oncology Issue: Volume 17:Issue 10(2015:Oct.) Page Start: 1386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ACTR-14. PHASE I STUDY OF AZD1775 WITH RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) AND EVALUATION OF INTRATUMORAL DRUG DISTRIBUTION (IDD) IN PATIENTS WITH RECURRENT GBM. (5th November 2018) Authors: Alexander, Brian; Supko, Jeffrey; Agar, Nathalie; Ahluwalia, Manmeet; Desai, Arati; Dietrich, Jorg; Kaley, Thomas; Peereboom, David; Takebe, Naoko; Desideri, Serena; Fisher, Joy; Sims, Megan; Ye, Xiaobu; Ligon, Keith; Nabors, L Burt; Grossman, Stuart; Wen, Patrick Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ACTR-37. ASSOCIATION BETWEEN MGMT PROMOTER METHYLATION SCORE AND SURVIVAL IN PATIENTS WITH GLIOBLASTOMA. (11th November 2019) Authors: Romo, Carlos; Shah, Pavan; Sun, Yuqing; Ye, Xiaobu; Grossman, Stuart Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ACTR-43. GENOMIC ANALYSIS OF RESPONDERS OF PHASE II TRIAL OF TEMOZOLOMIDE AND TRC-102 (BASE EXCISION REPAIR INHIBITOR) IN BEVACIZUMAB-NAÏVE GLIOBLASTOMA AT FIRST RECURRENCE. (11th November 2019) Authors: Ahluwalia, Manmeet; Dhruv, Harshil; Fallah, Jaleh; Berens, Michael; Drappatz, Jan; Ye, Xiaobu; Lesser, Glenn; Cloughesy, Timothy; Walbert, Tobias; Holdhoff, Matthias; Peereboom, David; Nabors, Louis; Wen, Patrick; Grossman, Stuart; Rogers, Lisa Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. ACTR-58. BASELINE REQUIREMENTS FOR NOVEL AGENTS BEING CONSIDERED FOR BRAIN CANCER EFFICACY TRIALS: REPORT OF AN ABTC WORKSHOP. (11th November 2019) Authors: Grossman, Stuart; Romo, Carlos; Rudek-Renaut, Michelle; Supko, Jeffrey; Fisher, Joy; Nabors, Burt; Wen, Patrick; Peereboom, David; Ellingson, Benjamin; Ye, Xiaobu Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas. Issue 1 (31st August 2018) Authors: Ho, Won Jin; Yarchoan, Mark; Hopkins, Alex; Mehra, Ranee; Grossman, Stuart; Kang, Hyunseok Journal: Journal for immunotherapy of cancer Issue: Volume 6:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CLRM-03 INCIDENCE OF INTRACRANIAL HEMORRHAGE IN GLIOMA PATIENTS WITH VENOUS THROMBOEMBOLISM CONVERTED FROM LMWH TO APIXABAN. (5th August 2022) Authors: Aboud, Orwa; Ye, Xiaobu; Grossman, Stuart Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 1 Page Start: i6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. CMET-02. ESTABLISHING THE SAFETY AND EFFICACY OF A NEW MULTI-AGENT INTRATHECAL TREATMENT PROTOCOL FOR PATIENTS WITH NEOPLASTIC MENINGITIS. (11th November 2019) Authors: Zammar, Samer; Eby, Richard; Zacharia, Brad; Strowd, Roy; Grossman, Stuart; Aregawi, Dawit; Michael, Glantz Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗